DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulationSsu-Chuan Lai(Taipei Medical University), Yen‐Hua Huang(Taipei Medical University Hospital)Journal of Experimental & Clinical Cancer ResearchNovember 26, 201910.1186/s13046-019-1442-2Cited by 127SaveCiteExport RISWatch citationsRelated PapersInflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma|PLoS ONE|2016|46